Business

Antibody Industry Share 2020-2026: Roche, Johnson & Johnson, Merck

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
In Vitro Diagnostics (IVD) are tests used to detect disease, infections and other medical conditions. The growing need of IVD testing arises due to increasing incidences of chronic and infectious diseases and growing geriatric population prone to immunological disorders. Moreover, increased application of personalized medicines and widespread knowledge of rare diseases are boosting the growth of IVD market. In the recent years, antibody used for IVD industry developed rapidly in China

There is a gap between China antibody manufacturers and Europe/America. In China, about 26% of consumption antibody import from foreign manufactures, such as Hytest, Roche, Thermo Fisher. There are also some local producers, such as Fapon, Genscript, Kitgen, Leadman, MACCURA, Wondfo, etc. Fapon is the leading player in China.

In classification, antibody can be divided into polyclonal antibody and monoclonal antibody. Monoclonal antibody hold the mostly share the China share about 91.12%.

Get Exclusive Sample of this Premium Report @ http://www.amecoresearch.com/sample/200868

In application, antibody downstream is wide and recently antibody has impacted by the hospital, medical research institutions, etc. Hospital holds about 91.21% of whole China antibody consumption in 2016.

The manufacture region is concentrated in Central China, East China and Southwest China, of which East China is the largest region with the share 33.20% in 2016. The sales shares of Southwest China and Central China were 15.12% and 14.56%.

In 2019, the global Antibody market size was US$ 8166.8 million and is forecast to US$ 11770 million in 2026, growing at a CAGR of 5.3% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Antibody.

The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Antibody market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Antibody market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Antibody market. Readers of the report can become informed about current and future trends of the global Antibody market and how they will impact market growth during the forecast period.

Buy This Premium Report At Special Financial Year End Sale Offer: http://www.amecoresearch.com/discount/200868

Single User Flat 10% Off | Multi-User Flat 15% Off

*Offer Valid Till 31st March 2020*

Geographic Segmentation

The report offers exhaustive assessment of different region-wise and country-wise Antibody markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.

For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Antibody market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.

Market Segmentation by Type and by Application

The report includes a detailed analysis of leading and by Type and by Application segments of the global Antibody market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Antibody market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Antibody market is segmented into

IgM

IgG

IgA

Other

Market Segment by Application, the Antibody market is segmented into

Therapeutic

Research

Diagnostic

This report includes the following manufacturers; we can also add the other companies as you want.

Roche

Johnson & Johnson

Merck

Novartis

AbbVie

Amgen

Pfizer

Bayer

Lilly

Bristol-Myers Squibb

GlaxoSmithKline

Biogen

AstraZeneca

Sanofi

Alexion Pharmaceuticals

Seattle Genetics

Any question before placing an order or any customization required, please feel free to contact: Click Here

 Table of Content

Global Antibody Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
1 Report Overview
1.1 Research Scope
1.2 Top Antibody Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Antibody Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 IgM
1.3.3 IgG
1.3.4 IgA
1.3.5 Other
1.4 Market Segment by Application
1.4.1 Global Antibody Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Therapeutic
1.4.3 Research
1.4.4 Diagnostic
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Antibody Revenue (2015-2026)
2.1.1 Global Antibody Revenue (2015-2026)
2.1.2 Global Antibody Sales (2015-2026)
2.2 Antibody Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Antibody Sales by Regions (2015-2020)
2.2.2 Global Antibody Revenue by Regions (2015-2020)
2.3 Global Top Antibody Regions (Countries) Ranking by Market Size
2.4 Antibody Industry Trends
2.4.1 Antibody Market Top Trends
2.4.2 Market Drivers
2.4.3 Antibody Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Antibody Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Antibody Manufacturers by Sales (2015-2020)
3.1.1 Global Antibody Sales by Manufacturers (2015-2020)
3.1.2 Global Antibody Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Antibody Sales in 2019
3.2 Global Top Manufacturers Antibody by Revenue
3.2.1 Global Antibody Revenue by Manufacturers (2015-2020)
3.2.2 Global Antibody Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antibody Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody as of 2019)
3.4 Global Antibody Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Antibody Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Antibody Market
3.7 Key Manufacturers Antibody Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Antibody Historic Market Review by Type (2015-2020)
4.1.2 Global Antibody Sales Market Share by Type (2015-2020)
4.1.3 Global Antibody Revenue Market Share by Type (2015-2020)
4.1.4 Antibody Price by Type (2015-2020)
4.1 Global Antibody Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Antibody Sales Forecast by Type (2021-2026)
4.2.3 Global Antibody Revenue Forecast by Type (2021-2026)
4.2.4 Antibody Price Forecast by Type (2021-2026)

5 Global Antibody Market Size by Application
5.1 Global Antibody Historic Market Review by Application (2015-2020)
5.1.2 Global Antibody Sales Market Share by Application (2015-2020)
5.1.3 Global Antibody Revenue Market Share by Application (2015-2020)
5.1.4 Antibody Price by Application (2015-2020)
5.2 Global Antibody Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Antibody Sales Forecast by Application (2021-2026)
5.2.3 Global Antibody Revenue Forecast by Application (2021-2026)
5.2.4 Antibody Price Forecast by Application (2021-2026)

6 North America
6.1 North America Antibody Breakdown Data by Company
6.2 North America Antibody Breakdown Data by Type
6.3 North America Antibody Breakdown Data by Application
6.4 North America Antibody Breakdown Data by Countries
6.4.1 North America Antibody Sales by Countries
6.4.2 North America Antibody Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Antibody Breakdown Data by Company
7.2 Europe Antibody Breakdown Data by Type
7.3 Europe Antibody Breakdown Data by Application
7.4 Europe Antibody Breakdown Data by Countries
7.4.1 Europe Antibody Sales by Countries
7.4.2 Europe Antibody Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Antibody Breakdown Data by Company
8.2 Asia Pacific Antibody Breakdown Data by Type
8.3 Asia Pacific Antibody Breakdown Data by Application
8.4 Asia Pacific Antibody Breakdown Data by Regions
8.4.1 Asia Pacific Antibody Sales by Regions
8.4.2 Asia Pacific Antibody Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Antibody Breakdown Data by Company
9.2 Latin America Antibody Breakdown Data by Type
9.3 Latin America Antibody Breakdown Data by Application
9.4 Latin America Antibody Breakdown Data by Countries
9.4.1 Latin America Antibody Sales by Countries
9.4.2 Latin America Antibody Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Antibody Breakdown Data by Type
10.2 Middle East and Africa Antibody Breakdown Data by Application
10.3 Middle East and Africa Antibody Breakdown Data by Countries
10.3.1 Middle East and Africa Antibody Sales by Countries
10.3.2 Middle East and Africa Antibody Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Roche Antibody Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Roche Antibody Products and Services
11.1.5 Roche SWOT Analysis
11.1.6 Roche Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Johnson & Johnson Antibody Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Johnson & Johnson Antibody Products and Services
11.2.5 Johnson & Johnson SWOT Analysis
11.2.6 Johnson & Johnson Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Merck Antibody Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Merck Antibody Products and Services
11.3.5 Merck SWOT Analysis
11.3.6 Merck Recent Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Novartis Antibody Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Novartis Antibody Products and Services
11.4.5 Novartis SWOT Analysis
11.4.6 Novartis Recent Developments
11.5 AbbVie
11.5.1 AbbVie Corporation Information
11.5.2 AbbVie Business Overview and Total Revenue (2019 VS 2018)
11.5.3 AbbVie Antibody Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 AbbVie Antibody Products and Services
11.5.5 AbbVie SWOT Analysis
11.5.6 AbbVie Recent Developments
11.6 Amgen
11.6.1 Amgen Corporation Information
11.6.2 Amgen Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Amgen Antibody Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Amgen Antibody Products and Services
11.6.5 Amgen SWOT Analysis
11.6.6 Amgen Recent Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Pfizer Antibody Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Pfizer Antibody Products and Services
11.7.5 Pfizer SWOT Analysis
11.7.6 Pfizer Recent Developments
11.8 Bayer
11.8.1 Bayer Corporation Information
11.8.2 Bayer Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Bayer Antibody Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Bayer Antibody Products and Services
11.8.5 Bayer SWOT Analysis
11.8.6 Bayer Recent Developments
11.9 Lilly
11.9.1 Lilly Corporation Information
11.9.2 Lilly Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Lilly Antibody Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Lilly Antibody Products and Services
11.9.5 Lilly SWOT Analysis
11.9.6 Lilly Recent Developments
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Corporation Information
11.10.2 Bristol-Myers Squibb Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Bristol-Myers Squibb Antibody Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Bristol-Myers Squibb Antibody Products and Services
11.10.5 Bristol-Myers Squibb SWOT Analysis
11.10.6 Bristol-Myers Squibb Recent Developments
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Corporation Information
11.11.2 GlaxoSmithKline Business Overview and Total Revenue (2019 VS 2018)
11.11.3 GlaxoSmithKline Antibody Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 GlaxoSmithKline Antibody Products and Services
11.11.5 GlaxoSmithKline SWOT Analysis
11.11.6 GlaxoSmithKline Recent Developments
11.12 Biogen
11.12.1 Biogen Corporation Information
11.12.2 Biogen Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Biogen Antibody Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Biogen Antibody Products and Services
11.12.5 Biogen SWOT Analysis
11.12.6 Biogen Recent Developments
11.13 AstraZeneca
11.13.1 AstraZeneca Corporation Information
11.13.2 AstraZeneca Business Overview and Total Revenue (2019 VS 2018)
11.13.3 AstraZeneca Antibody Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.13.4 AstraZeneca Antibody Products and Services
11.13.5 AstraZeneca SWOT Analysis
11.13.6 AstraZeneca Recent Developments
11.14 Sanofi
11.14.1 Sanofi Corporation Information
11.14.2 Sanofi Business Overview and Total Revenue (2019 VS 2018)
11.14.3 Sanofi Antibody Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.14.4 Sanofi Antibody Products and Services
11.14.5 Sanofi SWOT Analysis
11.14.6 Sanofi Recent Developments
11.15 Alexion Pharmaceuticals
11.15.1 Alexion Pharmaceuticals Corporation Information
11.15.2 Alexion Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.15.3 Alexion Pharmaceuticals Antibody Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.15.4 Alexion Pharmaceuticals Antibody Products and Services
11.15.5 Alexion Pharmaceuticals SWOT Analysis
11.15.6 Alexion Pharmaceuticals Recent Developments
11.16 Seattle Genetics
11.16.1 Seattle Genetics Corporation Information
11.16.2 Seattle Genetics Business Overview and Total Revenue (2019 VS 2018)
11.16.3 Seattle Genetics Antibody Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.16.4 Seattle Genetics Antibody Products and Services
11.16.5 Seattle Genetics SWOT Analysis
11.16.6 Seattle Genetics Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Antibody Sales Channels
12.2.2 Antibody Distributors
12.3 Antibody Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Antibody Sales Forecast (2021-2026)
13.1.1 Global Antibody Sales Forecast by Regions (2021-2026)
13.1.2 Global Antibody Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Antibody Sales Forecast (2021-2026)
13.2.2 North America Antibody Revenue Forecast (2021-2026)
13.2.3 North America Antibody Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Antibody Sales Forecast (2021-2026)
13.3.2 Europe Antibody Revenue Forecast (2021-2026)
13.3.3 Europe Antibody Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Antibody Sales Forecast (2021-2026)
13.4.2 Asia Pacific Antibody Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Antibody Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Antibody Sales Forecast (2021-2026)
13.5.2 Latin America Antibody Revenue Forecast (2021-2026)
13.5.3 Latin America Antibody Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Antibody Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Antibody Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Antibody Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Data is Ready Buy This Premium Report @ http://www.amecoresearch.com/buy/200868

 About Us:      

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making a purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact:

Email: sales@amecoresearch.com | +1 407 915 4157

Follow Us:-

Linkedin:  https://www.linkedin.com/company/ameco-research

Twitter: https://twitter.com/AmecoResearch

Comment here